T. Cantor

发表

Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions.

T. Cantor, Zan Yang, Nicolae Caraiani, 2006, Clinical chemistry.

Development of a Novel Immunoradiometric Assay Exclusively for Biologically Active Whole Parathyroid Hormone 1–84: Implications for Improvement of Accurate Assessment of Parathyroid Function

Sudhaker D. Rao, H. Schmidt-Gayk, P. D'amour, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism.

S. Silverberg, J. Bilezikian, P. Gao, 2003, The Journal of clinical endocrinology and metabolism.

Editorials: Parathyroid Hormone Assay Drift: An Unappreciated Problem in Dialysis Patient Management

T. Cantor, 2005, Seminars in dialysis.

High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis.

H. Malluche, D. Davenport, M. Monier‐Faugere, 2015, Journal of the American Society of Nephrology : JASN.

Changes in bone mineral parameters, vitamin D metabolites, and PTH measurements with varying chronic kidney disease stages

W. Fraser, Sanjeev Patel, J. Barron, 2010, Journal of Bone and Mineral Metabolism.

A novel mechanism for skeletal resistance in uremia.

A. Dusso, E. Slatopolsky, G. Sicard, 2000, Kidney international.

Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.

H. Malluche, D. Davenport, M. Monier‐Faugere, 2014, Clinical journal of the American Society of Nephrology : CJASN.

The five most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patients.

A. Branscum, H. Malluche, M. Monier‐Faugere, 2009, Clinical nephrology.

Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia.

M. Fukagawa, P. D'amour, T. Cantor, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Parathyroid hormone and growth in children with chronic renal failure.

L. Rees, D. Ridout, T. Cantor, 2005, Kidney international.

Correspondence: iPTH Treatment Guidelines for Caucasian versus African‐American Hemodialysis Patients

T. Cantor, 2007, Seminars in dialysis.

Effect of megestrol acetate (Megace) on steroid metabolism and steroid-protein binding in the human prostate.

S. Yen, J. Geller, T. Cantor, 1976, The Journal of clinical endocrinology and metabolism.

Decreased expression of caveolin-1 and altered regulation of mitogen-activated protein kinase in cultured bovine parathyroid cells and human parathyroid adenomas.

E. Brown, F. Moore, P. Gao, 2003, The Journal of clinical endocrinology and metabolism.

Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.

N. Powe, J. Coresh, N. Fink, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Vitamin D status and redefining serum parathyroid hormone reference range in the elderly.

E. Baulieu, J. Souberbielle, C. Cormier, 2001, The Journal of clinical endocrinology and metabolism.

An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma.

M. Rubin, J. Sliney, S. Silverberg, 2007, Clinical chemistry.

Overproduction of an amino‐terminal form of PTH distinct from human PTH(1–84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery

C. Albert, P. D'amour, A. Räkel, 2005, Clinical endocrinology.

Vitamin D status and redefining serum parathyroid hormone reference range in the elderly.

E. Baulieu, J. Souberbielle, C. Cormier, 2001, The Journal of clinical endocrinology and metabolism.

Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism.

E. Brown, A. McElduff, F. Moore, 2004, The Journal of clinical endocrinology and metabolism.

High serum levels of a non-(1–84) parathyroid hormone (PTH) fragment in pediatric haemodialysis patients

J. Souberbielle, P. Niaudet, M. Charbit, 2001, Pediatric Nephrology.

A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure.

H. Jüppner, W. Goodman, I. Salusky, 1999, The Journal of clinical endocrinology and metabolism.

Evidence that the amino-terminal composition of non-(1-84) parathyroid hormone fragments starts before position 19.

C. Albert, P. D'amour, A. Räkel, 2005, Clinical chemistry.

The opposing actions of the two parathyroid hormones, 1‐84 PTH and 7‐84 PTH: Improvement in renal bone and calcium metabolism management

T. Cantor, 2004, Hemodialysis international. International Symposium on Home Hemodialysis.

Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidism.

P. D'amour, P. Gao, L. Roy, 2003, Clinical chemistry.

Nontruncated amino‐terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation

M. Rubin, J. Bilezikian, W. Simonds, 2011, Clinical endocrinology.

Circadian variation of mineral and bone parameters in end-stage renal disease

H. Raff, A. Szabo, H. Trivedi, 2015, Journal of Nephrology.

IRMA (whole PTH) is a more useful assay for the effect of PTH on bone than the Allegro intact PTH assay in CAPD patients with low bone turnover marker.

T. Shigematsu, T. Hosoya, Hiroyasu Yamamoto, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Influence of Secondary Hyperparathyroidism Induced by Low Dietary Calcium, Vitamin D Deficiency, and Renal Failure on Circulating Rat PTH Molecular Forms

P. D'amour, T. Cantor, Zan Yang, 2011, International journal of endocrinology.

Validation and clinical utility of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone in the horse.

J. Estepa, P. Gao, E. Aguilera-Tejero, 2010, Equine veterinary journal.

Origin of parathyroid hormone (PTH) fragments detected by intact-PTH assays.

L. Nguyen-Yamamoto, R. Lepage, P. D'amour, 2002, European journal of endocrinology.

A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor.

J. Garber, E. Brown, J. Wysolmerski, 2003, The Journal of clinical endocrinology and metabolism.

Intraoperative parathyroid hormone levels measured by intact and whole parathyroid hormone assays in patients with Graves’ disease

T. Moriyama, H. Yamashita, S. Noguchi, 2008, Surgery Today.

Sequential Changes in Plasma Intact and Whole Parathyroid Hormone Levels during Parathyroidectomy for Secondary Hyperparathyroidism

T. Moriyama, M. Fukagawa, H. Yamashita, 2005, World Journal of Surgery.

Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism.

M. Fukagawa, P. Gao, H. Yamashita, 2004, Surgery.

Dynamics of PTH secretion in hemodialysis patients as determined by the intact and whole PTH assays.

P. Aljama, A. Martín-Malo, Mariano Rodríguez, 2003, Kidney international.

Parathyroid hormone and its fragments in children with chronic renal failure

L. Rees, D. Ridout, P. Gao, 2003, Pediatric Nephrology.

Large carboxy-terminal parathyroid hormone (PTH) fragment with a relatively longer half-life than 1-84 PTH is secreted directly from the parathyroid gland in humans.

M. Fukagawa, P. Gao, H. Yamashita, 2003, European journal of endocrinology.

Dynamics of secretion and metabolism of PTH during hypo- and hypercalcaemia in the dog as determined by the 'intact' and 'whole' PTH assays.

J. Estepa, P. Gao, E. Aguilera-Tejero, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Role of Cyclase Activating Parathyroid Hormone (1-84 PTH) Measurements During Parathyroid Surgery: Potential Improvement of Intraoperative PTH Assay

M. Fukagawa, P. Gao, H. Yamashita, 2002, Annals of surgery.

Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients.

T. Shigematsu, M. Fukagawa, J. Kazama, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Acute regulation of circulating parathyroid hormone (PTH) molecular forms by calcium: utility of PTH fragments/PTH(1-84) ratios derived from three generations of PTH assays.

C. Albert, P. D'amour, A. Räkel, 2006, The Journal of clinical endocrinology and metabolism.

Differences between ‘intact’ PTH and 1–84 PTH assays in chronic renal failure and dialysis

L. Rees, D. Ridout, T. Cantor, 2005, Pediatric Nephrology.

Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.

I. Narita, Yumi Ito, F. Gejyo, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients.

H. Malluche, M. Monier‐Faugere, Z. Geng, 2001, Kidney international.

Evidence for a specific dihydrotestosterone-binding cytosol receptor in the human prostate.

J. Geller, T. Cantor, J. Albert, 1975, The Journal of clinical endocrinology and metabolism.

The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.

T. Cantor, B. Sci, 2003, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients.

C. Baudoin, P. Ureña, M. de Vernejoul, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study.

A. Branscum, H. Malluche, M. Monier‐Faugere, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

7-84 PTH lowers bone turnover and explains why the 1-84 PTH/7-84 PTH ratio predicts bone turnover.

T. Cantor, 2004, Kidney international.

891 ETIOLOGY OF FIRST DAY HYPOCALCEMIA (FDH): ROLE OF PTH AND CALCITONIN?

L. Deftos, D. Fisher, W. Odell, 1978, Pediatric Research.

Absence of adynamic bone disease in African-Americans with CKD stage 5 after 3 years of vitamin D therapy guided by iPTH and the PTH-(1-84)/N-terminally truncated PTH fragments ratio.

J. Yee, H. Malluche, Y. Osman, 2009, Clinical nephrology.

Rat parathyroid hormone (rPTH) ELISAs specific for regions (2-7), (22-34) and (40-60) of the rat PTH structure: influence of sex and age.

P. D'amour, T. Cantor, Zan Yang, 2010, General and comparative endocrinology.

Effect of cyproterone acetate on clinical, endocrine and pathological features of benign prostatic hypertrophy.

J. Geller, T. Cantor, J. Fishman, 1975, Journal of steroid biochemistry.

Lack of evidence for administering vitamin D analogs to kidney failure patients to improve survivability.

T. Cantor, 2009, Clinical nephrology.